Literature DB >> 9227349

The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats.

H Ogata1, M Takeya, T Yoshimura, K Takagi, K Takahashi.   

Abstract

Collagen-induced arthritis was produced in rats by intradermal immunization with type II collagen and the expression and production of monocyte chemoattractant protein-1 (MCP-1) were examined by immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), and Northern blot analysis. Two to three weeks after the immunization, the hindfeet showed swelling and redness, followed by the development of severe arthritis, particularly in the ankle joints. During this period, prominent infiltration of neutrophils and macrophages was observed. Sandwich ELISA and Northern blot analysis revealed that MCP-1 concentrations in the joint lavages and MCP-1 mRNA levels in the joint tissues both peaked at 2 weeks after the immunization. By immunohistochemistry, various types of cells, particularly neutrophils, macrophages, synovial cells, and vascular endothelial cells, stained positively for MCP-1. Finally, injection of a neutralizing monoclonal antibody against rat MCP-1 significantly decreased the number of exudate macrophages in the lesions and reduced the ankle swelling by about 30 per cent compared with controls. These results suggest that MCP-1 plays a critical role in this model in the recruitment of monocytes and in the development of arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227349     DOI: 10.1002/(SICI)1096-9896(199705)182:1<106::AID-PATH816>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  42 in total

1.  Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model.

Authors:  Jonathan P Jacobs; Adriana Ortiz-Lopez; James J Campbell; Craig J Gerard; Diane Mathis; Christophe Benoist
Journal:  Arthritis Rheum       Date:  2010-07

2.  MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production.

Authors:  Toshiyuki Okuma; Yasuhiro Terasaki; Naomi Sakashita; Koichi Kaikita; Hironori Kobayashi; Takanori Hayasaki; William A Kuziel; Hideo Baba; Motohiro Takeya
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

Review 3.  G protein betagamma subunits as targets for small molecule therapeutic development.

Authors:  Alan V Smrcka; David M Lehmann; Axel L Dessal
Journal:  Comb Chem High Throughput Screen       Date:  2008-06       Impact factor: 1.339

Review 4.  G protein βγ subunits: central mediators of G protein-coupled receptor signaling.

Authors:  A V Smrcka
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

5.  Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.

Authors:  E M Paleolog; R A Fava
Journal:  Springer Semin Immunopathol       Date:  1998

Review 6.  Chemokines in rheumatoid arthritis.

Authors:  Z Szekanecz; R M Strieter; S L Kunkel; A E Koch
Journal:  Springer Semin Immunopathol       Date:  1998

7.  A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo.

Authors:  Patrick Williams; Moutih Rafei; Manaf Bouchentouf; Jennifer Raven; Shala Yuan; Jessica Cuerquis; Kathy A Forner; Elena Birman; Jacques Galipeau
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

Review 8.  Chemokine receptor antagonists: overcoming developmental hurdles.

Authors:  Richard Horuk
Journal:  Nat Rev Drug Discov       Date:  2008-12-12       Impact factor: 84.694

Review 9.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

10.  Effects of induction therapy on wound healing at bronchial anastomosis sites in rats.

Authors:  Tomoyuki Shirafuji; Tadayuki Oka; Takahiro Sawada; Kazuki Tamura; Takeshi Nagayasu; Motohiro Takeya; Teizo Yoshimura; Hiroyoshi Ayabe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.